Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00175786
Other study ID # C04-0404
Secondary ID
Status Completed
Phase N/A
First received September 13, 2005
Last updated September 24, 2008
Start date July 2005

Study information

Verified date September 2008
Source University of British Columbia
Contact n/a
Is FDA regulated No
Health authority Canada: Health Canada
Study type Observational

Clinical Trial Summary

The purpose of this study is to study the occurrence rate of masses such as brain tumors in patients with newly diagnosed Normal Tension Glaucoma.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Lack of understanding of the study

- Unable or unwilling to undergo MRI

Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Canada Vancouver Hospital and Health Sciences Centre Vancouver British Columbia

Sponsors (1)

Lead Sponsor Collaborator
University of British Columbia

Country where clinical trial is conducted

Canada, 

See also
  Status Clinical Trial Phase
Completed NCT01995136 - Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma Phase 4
Completed NCT00706056 - A New View of Normal Tension Glaucoma: Autoregulation and Systemic Blood Pressure N/A
Not yet recruiting NCT05075369 - Water Drinking Test Study and Disc Hemorrhages in Normal Tension Glaucoma N/A
Completed NCT01769521 - Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG N/A
Recruiting NCT01446497 - Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension Glaucoma Phase 4
Terminated NCT01864317 - Assessment of Optic Nerve Radiation in Patients With Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor Imaging Phase 2
Not yet recruiting NCT00739154 - Protective Effect of Phenytoin on Glaucoma N/A
Recruiting NCT03761992 - Measurement of the Effect of Gingko Biloba Extract on Ocular and Nailfold Blood-flow in NTG N/A
Recruiting NCT05371977 - Deep Sclerectomy Versus Trabeculectomy in Normal Tension Glaucoma N/A
Completed NCT03106532 - Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma Phase 2
Completed NCT01175902 - Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension Glaucoma N/A
Completed NCT01488032 - Differences in Nerve Fiber Layer Between Patients With Normal- and High-Pressure-Glaucoma N/A
Completed NCT00570362 - Systemic Glutathione Level in Normal Tension Glaucoma N/A
Recruiting NCT06449352 - Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost Phase 4
Not yet recruiting NCT06023927 - Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness
Completed NCT04475900 - Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics
Completed NCT02863705 - Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG) Phase 4
Completed NCT03323164 - Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study Phase 4
Completed NCT04014933 - Reproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI System
Recruiting NCT01794442 - Study on the Oxygen Saturation in Pulsating and Non-pulsating Central Retinal Veins N/A